期刊文献+

MJ15对大麻素Ⅰ型受体的阻滞及反相激动作用的研究

Antagonistic and inverse agonistic effect of MJ15 on cannabinoid receptors Ⅰ
原文传递
导出
摘要 目的:观察MJ15对大麻素Ⅰ型(cannabinoid receptorsⅠ,CB1)受体的阻滞及反相激动作用。方法:制备小鼠输精管和豚鼠回肠平滑肌的离体标本,观察CB1受体激动剂WIN55212-2以及阻滞剂利莫那班(SR141716A)和MJ15对其收缩特性的影响。结果:CB1受体激动剂WIN55212-2(10-10~10-6 mol.L-1)可抑制电刺激所引起小鼠输精管的收缩作用,呈现明显的剂量依赖性,而SR141716A和MJ15(10-7 mol.L-1)能阻滞WIN55212-2的抑制作用;CB1受体激动剂WIN55212-2可抑制豚鼠回肠和小鼠输精管平滑肌的收缩,而SR141716A和MJ15能促进豚鼠回肠和小鼠输精管平滑肌的收缩。结论:MJ15是CB1受体的阻滞剂,同时具有反相激动作用。 Objective:To observe the antagonistic and inverse agonistic effect of MJ15 on cannabinoid receptors Ⅰ(CB1).Methods:The samples of the ileum smooth muscle isolated from guinea pigs and vas deferens isolated from mice were put into the Magnus' bath,and the contractive activities were investigated.Results:The CB1 receptor agonist WIN55212-2(10-10~10-6 mol·L-1) inhibited electrically induced contraction of mouse vas deferens;the concentration-dependency was significant.The concentration-response curse was completely inhibited by SR141716A and MJ15(10-7 mol·L-1).WIN55212-2 inhibited contraction of mouse vas deferens and guinea pig ileum smooth muscle;while SR141716A and MJ15 accelerated the contraction.Conclusion:MJ15 is an antagonist of CB1 receptor with inverse agonistic activity.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第5期417-421,共5页 Chinese Journal of New Drugs
基金 重大新药创制科技重大专项(2009ZX09301-002)
关键词 大麻素Ⅰ型受体 MJ15 阻滞作用 反相激动作用 cannabinoid receptor Ⅰ MJ15 antagonistic effect inverse agonistic effect
  • 相关文献

参考文献10

  • 1MATSUDA LA, LOLAIT SJ, BROWNSEIN M,et al. Structure of a cannabinoid receptor and functional expression of the cloned CDNA[J]. Nature, 1990, 346(6284) : 561 -564. 被引量:1
  • 2PERTWEE RG. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors [ J ]. Life Sci, 2005, 76 (12) : 1307 - 1324. 被引量:1
  • 3曾凡新,董志,傅洁民,邓杰.减肥药的作用新靶点及相关新药研发近况[J].药学进展,2006,30(1):23-29. 被引量:10
  • 4TSENG SL, HUNG MS, CHANG CP,et al. Bioisosteric replacement of the pyrazole 5-aryl moiety of N-(piperidin-l-yl) -5-(4- chlorophenyl ) -1 - ( 2,4-dichlorophenyl ) - 4-methyl-1 H-pyrazole-3- carboxamide(SR141716A). A novel series of alkynylthiophenes as potent and selective cannabinoid-1 receptor antagonists [ J ]. J Med Chem, 2008, 51(17): 5397-5412. 被引量:1
  • 5FREMMING BA, BOYD ST. Taranabant, a novel cannabinoid type 1 receptor inverse agonist [ J ] . Curr Opin Investig Drugs, 2008, 9(10) : 1116 - 1129. 被引量:1
  • 6IZZO AA, MASCOLO N, TONINI M,et al. Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea-pig ileum[J]. Br J Pharmacol, 2000, 129(5) : 984 -990. 被引量:1
  • 7PERTWEE RG, GRIFFIN G, LAINTON JA,et al. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens[ J]. Eur J Pharmacol, 1995, 284(3) :241 -247. 被引量:1
  • 8胡国胜,黄先菊.DDPH对多种介质所致豚鼠离体肠道平滑肌收缩的影响[J].中国临床药理学与治疗学,1999,4(2):143-146. 被引量:1
  • 9洪民华,池志强,刘景根.G蛋白偶联受体固有活性研究进展与新药开发[J].中国药理学通报,2005,21(9):1030-1033. 被引量:6
  • 10CHRISTOPOULOS A, COLES P, LAY L. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens[ J]. Br J Pharmacol, 2001, 132(6) : 1281 - 1291. 被引量:1

二级参考文献30

  • 1Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: Cause of disease and common property of wild-type receptors[J]. Naunyn-Schmiedebergs Arch Pharmacol,2002,366: 381-416. 被引量:1
  • 2Chen G, Way J, Armour S et al. Use of Constitutive G protein-coupled receptor activity for drug discovery. Mol Pharmacol,2000,57: 125-34. 被引量:1
  • 3Ren Q, Kurose H, Lefkowitz RJ, Cotecchia S. Constitutively active mutants of the 2-adrenergic receptor[J]. J Biol Chem,1993, 268:16483-7. 被引量:1
  • 4Zaki PA, Keith DEJr, Thomas JB et al. Agonist-,Antagonist-,and inverse agonist-regulated trafficking of the-opioid receptor correlates with,but does not require, G protein activation[J]. J Pharmacol Exp Ther,2001,298(3): 1015-20. 被引量:1
  • 5Seifert R, Wenzel-Seifert K. The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors[J]. Life Sci,2003,73(18):2263-80. 被引量:1
  • 6Cussac D, Pasteau V, Mark J. Millan Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine[J]. Eur J Pharmacol,2004,485:111-7. 被引量:1
  • 7Richard F, Barroso S, Martinez J et al. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2[J]. Mol Pharmacol, 2001,60(6):1392-8. 被引量:1
  • 8Egan CT, Herrick-Davis K, Teithlr M. Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs. J Pharmacol Exp, 1998,286(1):85-90. 被引量:1
  • 9Jinsi-Parimoo A,Gershengom MC. Constitutive activity of native thyrotropin-releasing hormone receptors revealed using a protein kinase C-responsive reporter gene. Endocrinology J,1997,138(4):1471-5. 被引量:1
  • 10Wilbanks AM, Laporte SA, Bohn LM et al. Apparent loss-of-function mutant GPCRs revealed as constitutively desensitized receptors. Biochemistry,2002,41(40):11981-9. 被引量:1

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部